Abnormal expression of molecules in the TGF-β/SMAD signaling pathway has been previously demonstrated in lung tissues from COPD patients25, and the changes in TGF-β precedes visible changes in lung pathology and function. Here, TGFB1 is linked to chronic obstructive pulmonary disease.